The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Moskvina L.V.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossii

Andreeva Yu.Yu.

Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia

Frank G.A.

Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Rosmedtekhnologiĭ, Moskva

Zavalishina L.É.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

Petrov A.N.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava RF

Mal'kov P.G.

GUNU "Fakul'tet fundamental'noĭ meditsiny MGU im. M.V. Lomonosova";
GBOU DPO "Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia", Moskva

Prognostic value of the expression of adhesion molecules for non-clear-cell variants of renal cell carcinoma

Authors:

Moskvina L.V., Andreeva Yu.Yu., Frank G.A., Zavalishina L.É., Petrov A.N., Mal'kov P.G.

More about the authors

Journal: Russian Journal of Archive of Pathology. 2013;75(4): 3‑8

Read: 1343 times

Download PDF (RU)
Contact the author
Table of contents

PROGNOSTIC VALUE OF THE EXPRESSION OF ADHESION MOLECULES FOR NON-CLEAR-CELL VARIANTS OF RENAL CELL CARCINOMA
PROGNOSTIC VALUE OF THE EXPRESSION OF ADHESION MOLECULES FOR NON-CLEAR-CELL VARIANTS OF RENAL CELL CARCINOMA

To cite this article:

Moskvina LV, Andreeva YuYu, Frank GA, Zavalishina LÉ, Petrov AN, Mal'kov PG. Prognostic value of the expression of adhesion molecules for non-clear-cell variants of renal cell carcinoma. Russian Journal of Archive of Pathology. 2013;75(4):3‑8. (In Russ.)

 
Подписка 2026 Архив патологии (Russian Journal of Archive of Pathology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Cardiac myxoma: biological features, morphology, differential diagnosis. Russian Journal of Archive of Pathology. 2024;(6):74-81
Quality control of immu­nohistochemical studies: compulsory duty or urgent need?. Russian Journal of Archive of Pathology. 2025;(2):43-52
Placenta increta into the scar in combination with high-grade squamous intraepithelial lesion of the cervix. Russian Journal of Archive of Pathology. 2025;(2):64-68
The phenomenon of tumor budding in gastric cancer. Russian Journal of Archive of Pathology. 2025;(2):79-87
Differential Diagnosis of Perianal Skin Neoplasms. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):673-678
Clinical Case of HIV-Associated Kaposi’s Sarcoma. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):782-786
Difficult intu­bation risk asse­ssment in bariatric surgery. Russian Journal of Anesthesiology and Reanimatology. 2025;(1):62-68
Analysis of dyna­mics and fore­cast of morbidity of diseases of the urogenital system in the child popu­lation living in the Repu­blic of Sakha (Yakutia). Russian Journal of Preventive Medi­cine. 2025;(3):60-66
Rela­tionship between stroke-associated pneumonia and long-term outcomes of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):57-61
Prognostic significance of NT-proBNP and sST2 in patients with chro­nic heart failure and redu­ced ejection fraction after previous deco­mpensation. Russian Cardiology Bulletin. 2025;(1):49-56
Abstract:

The prognostic value of the expression of the adhesion molecules CD44, EMA, and E-cadherin was studied using surgical specimens of 105 renal cell carcinomas (54 papillary, 39 chromophobic, and 12 clear-cell ones). Stages 3-4 tumors showed hyperexpression of all the above proteins (the distribution was estimated by ξ2 and Fisher's exact tests). Furthermore, CD44 was found to be an independent unfavorable factor to predict renal cell carcinoma: with its hyperexpression, the 5-year estimated survival rate decreased by 52% (Kaplan-Meier method; p=0.018). The expression of EMA and E-cadherin was significantly associated with the stage and, to some extent, grade of tumor differentiation; however, it is necessary to study more observations to define the prognostic role of these proteins.

Keywords:

non-clear-cell renal cell carcinoma
immunohistochemistry
prognosis

Authors:

Moskvina L.V.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossii

Andreeva Yu.Yu.

Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia

Frank G.A.

Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena Rosmedtekhnologiĭ, Moskva

Zavalishina L.É.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

Petrov A.N.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava RF

Mal'kov P.G.

GUNU "Fakul'tet fundamental'noĭ meditsiny MGU im. M.V. Lomonosova";
GBOU DPO "Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia", Moskva

Close metadata

References:

  1. Eble J.N., Sauter G., Epstein J.I., Sesterhenn I.A. Tumors of the system and male genital organs. Lyon, France: IARC Press; 2004.
  2. Iczkowski K.A. Cell adhesion molecule CD44: its functional roles in prostate cancer. Am. J. Transl. Res. 2010; 3 (1): 1-7.
  3. Danilova N.V., Andreeva Yu.Yu., Zavalishina L.E., Mal'kov P.G. Markery stromal'noi invazii pri fonovykh i predrakovykh izmeneniyakh zhelezistogo epiteliya i adenokartsinome sheiki matki. Arkhiv patologii. 2012; 74 (4): 28-34.
  4. Kan M., Aki M., Akiyama K., Naruo S., Kanayama H., Kagawa S. High-level expression of the CD44 variant sharing exon v10 in renal cancer. Jpn. J. Cancer Res. 1995; 86 (9): 847-53.
  5. Terpe H.J., Störkel S., Zimmer U., Anquez V., Fischer C., Pantel K., Günthert U. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation. Am. J. Pathol. 1996; 148 (2): 453-63.
  6. Paradis V., Ferlicot S., Ghannam E., Zeimoura L., Blanchet P., Eschwége P. et al. CD44 is an independent prognostic factor in conventional renal cell carcinomas. J. Urol. 1999; 161 (6): 1984-7.
  7. de Alava E., Panizo A., Sola I., Rodríguez-Rubio F.I., Pardo-Mindán F.J. CD44v6 expression is related to progression in renal epithelial tumours. Histopathology. 1998; 33 (1): 39-45.
  8. Kroeze S.G., Bijenhof A.M., Bosch J.L., Jans J.J. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma. Cancer Biomark. 2010; 7 (6): 261-8.
  9. Yildiz E., Gokce G., Kilicarslan H., Ayan S., Goze O.F., Gultekin E.Y. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma. Br. J. Urol. Int. 2004; 93 (7): 1087-93.
  10. Ljungberg B., Cowan N., Hanbury D.C., Hora M., Kuczyk M.A., Merseburger A.S. et al. Pochechno-kletochnyi rak. 2011. http://www.uroweb.org/gls/pdf/russian/4_Renall_Cell_Carcinoma.pdf
  11. Li Y., Kuwahara H., Ren J. et al. The c-Src tyrosinase kinase regulates signalling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin. J. Biol. Chem. 2001; 276: 6061-4.
  12. Langner C., Ratschek M., Rehak P., Schips L., Zigeuner R. Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases. Mod. Pathol. 2004; 17 (2): 180-8.
  13. Bamias A., Chorti M., Deliveliotis C. et al. Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma. Urology. 2003; 62: 368-73.
  14. Denda-Nagai K., Fujita K., Fujime M. et al. Absence of correlation of MUC1 expression to malignant behavior of renal cell carcinoma in experimental systems. Clin. Exp. Metast. 2000; 18: 77-81.
  15. Aubert S., Fauquette V., Hémon B., Lepoivre R., Briez N., Bernard D. et al. MUC1, a new hypoxia inducible factor target gene, is an actor in clear renal cell carcinoma tumor progression. Cancer Res. 2009; 69 (14): 5707-15. doi: 10.1158/0008-5472.CAN-08-4905.
  16. Shen S.S., Truong L.D., Scarpelli M., Lopez-Beltran A. Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful? Arch. Pathol. Lab. Med. 2012; 136 (4): 410-7.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.